Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Gains from Sales and Divestitures (2024 - 2025)

Historic Gains from Sales and Divestitures for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q3 2025 value amounting to $205360.0.

  • Artiva Biotherapeutics' Gains from Sales and Divestitures changed N/A to $205360.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $205360.0, marking a year-over-year change of. This contributed to the annual value of $22514.0 for FY2024, which is N/A changed from last year.
  • Per Artiva Biotherapeutics' latest filing, its Gains from Sales and Divestitures stood at $205360.0 for Q3 2025.
  • In the past 5 years, Artiva Biotherapeutics' Gains from Sales and Divestitures registered a high of $205360.0 during Q3 2025, and its lowest value of $22514.0 during Q4 2024.